BioArctic: A bit stronger Q4 than expected, BMS deal a validation of BT technology - Redeye
Bildkälla: Stockfoto

BioArctic: A bit stronger Q4 than expected, BMS deal a validation of BT technology - Redeye

Redeye return with a research update following BioArctic's Q4 report and recent events, including the significant BMS deal and EU process, which overall leads to a slightly raised valuation.

Redeye return with a research update following BioArctic's Q4 report and recent events, including the significant BMS deal and EU process, which overall leads to a slightly raised valuation.
Börsvärldens nyhetsbrev
ANNONSER